Posted On: 12/12/2016 6:45:54 AM
Post# of 104845
$OPHT: -$30>>Ophthotech Announces Results from Pivotal Phase 3 Trials of Fovista® in Wet Age-Related Macular Degeneration
http://www.otcmarkets.com/stock/OPHT/news
http://www.otcmarkets.com/stock/OPHT/news
(0)
(0)
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.
Scroll down for more posts ▼
